| AstraZeneca AG - Imjudo 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68706 | | 02 | | Imjudo 300 mg/15 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX20 | | | | 13.09.2023 | | |
|
| Composition |
| tremelimumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, dinatrii edetas corresp. natrium 0.185 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Tremelimumabum | 300mg / 15ml |
| | BAG: Active Agent | Dose |
|---|
| Tremelimumabum | 300 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Trehalosum Dihydricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 17144.04 | 17897.60 | A | SL | No |
|
